West Pharmaceutical Earnings Estimate

WST Stock

USD 336.34 0.86 0.26%

The next projected EPS of West Pharmaceutical is estimated to be 1.71 with future projections ranging from a low of 1.5975 to a high of 1.68. West Pharmaceutical's most recent 12-month trailing earnings per share (EPS TTM) is at 6.74. Please be aware that the consensus of earnings estimates for West Pharmaceutical Services is based on EPS before non-recurring items and includes expenses related to employee stock options.

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

West Pharmaceutical is projected to generate 1.71 in earnings per share on the 31st of December 2024. West Pharmaceutical earnings estimates show analyst consensus about projected West Pharmaceutical Services EPS (Earning Per Share). It derives the highest and the lowest estimates based on West Pharmaceutical's historical volatility. Many public companies, such as West Pharmaceutical, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing West Pharmaceutical's earnings estimates, investors can diagnose different trends across West Pharmaceutical's analyst sentiment over time as well as compare current estimates against different timeframes. At this time, West Pharmaceutical's Gross Profit is comparatively stable compared to the past year. Pretax Profit Margin is likely to gain to 0.22 in 2025, whereas Gross Profit Margin is likely to drop 0.26 in 2025.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

West Pharmaceutical Earnings Estimation Breakdown

The calculation of West Pharmaceutical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of West Pharmaceutical is estimated to be 1.71 with the future projection ranging from a low of 1.5975 to a high of 1.68. Please be aware that this consensus of annual earnings estimates for West Pharmaceutical Services is based on EPS before non-recurring items and includes expenses related to employee stock options.

Last Reported EPS

1.85

1.60

Lowest

Expected EPS

1.71

1.68

Highest

West Pharmaceutical Earnings Projection Consensus

Suppose the current estimates of West Pharmaceutical's value are higher than the current market price of the West Pharmaceutical stock. In this case, investors may conclude that West Pharmaceutical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and West Pharmaceutical's stock will quickly adjusts to the new information provided by the consensus estimate.

Number of Analysts	Historical Accuracy	Last Reported EPS		Estimated EPS for 31st of December 2024	Current EPS (TTM)
11	86.96%	1.85		1.71	6.74

West Pharmaceutical Earnings History

Earnings estimate consensus by West Pharmaceutical analysts from Wall Street is used by the market to judge West Pharmaceutical's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only West Pharmaceutical's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

West Pharmaceutical Quarterly Gross Profit

264.7 Million

At this time, West Pharmaceutical's Retained Earnings are comparatively stable compared to the past year. Retained Earnings Total Equity is likely to gain to about 3.6 B in 2025, whereas Price Earnings Ratio is likely to drop 23.18 in 2025. Net Income Applicable To Common Shares is likely to gain to about 707.5 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 74.7 M in 2025.

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of West Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
333.38	336.23	339.08

Details

Intrinsic

Valuation

Low	Real	High
323.87	326.72	369.97

Details

12 Analysts

Consensus

Low	Target	High
345.66	379.85	421.63

Details

Note that many institutional investors and large investment bankers can move markets due to the volume of West assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards West Pharmaceutical. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving West Pharmaceutical's stock price in the short term.

West Pharmaceutical Earnings per Share Projection vs Actual

Actual Earning per Share of West Pharmaceutical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering West Pharmaceutical Services predict the company's earnings will be in the future. The higher the earnings per share of West Pharmaceutical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

West Pharmaceutical Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as West Pharmaceutical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of West Pharmaceutical should always be considered in relation to other companies to make a more educated investment decision.

West Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact West Pharmaceutical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2024-10-24	2024-09-30	1.5	1.85	0.35	23
2024-07-25	2024-06-30	1.74	1.52	-0.22	12
2024-04-25	2024-03-31	1.26	1.56	0.3	23
2024-02-15	2023-12-31	1.78	1.83	0.05	2
2023-10-26	2023-09-30	1.86	2.16	0.3	16
2023-07-27	2023-06-30	1.93	2.11	0.18	9
2023-04-27	2023-03-31	1.67	1.98	0.31	18
2023-02-16	2022-12-31	1.38	1.77	0.39	28
2022-10-27	2022-09-30	2.12	2.03	-0.09	4
2022-07-28	2022-06-30	2.21	2.47	0.26	11
2022-04-28	2022-03-31	2.12	2.3	0.18	8
2022-02-17	2021-12-31	1.92	2.04	0.12	6
2021-10-28	2021-09-30	1.8	2.06	0.26	14
2021-07-29	2021-06-30	1.74	2.46	0.72	41
2021-04-29	2021-03-31	1.43	2.05	0.62	43
2021-02-18	2020-12-31	1.13	1.34	0.21	18
2020-10-22	2020-09-30	1	1.15	0.15	15
2020-07-23	2020-06-30	0.91	1.25	0.34	37
2020-04-23	2020-03-31	0.82	1.01	0.19	23
2020-02-13	2019-12-31	0.72	0.82	0.1	13
2019-10-24	2019-09-30	0.71	0.79	0.08	11
2019-07-25	2019-06-30	0.72	0.89	0.17	23
2019-04-25	2019-03-31	0.66	0.74	0.08	12
2019-02-14	2018-12-31	0.72	0.73	0.01	1
2018-10-25	2018-09-30	0.7	0.76	0.06	8
2018-07-26	2018-06-30	0.67	0.7	0.03	4
2018-04-26	2018-03-31	0.64	0.62	-0.02	3
2018-02-15	2017-12-31	0.63	0.64	0.01	1
2017-10-26	2017-09-30	0.53	0.67	0.14	26
2017-07-27	2017-06-30	0.65	0.66	0.01	1
2017-04-27	2017-03-31	0.55	0.6	0.05	9
2017-02-16	2016-12-31	0.56	0.54	-0.02	3
2016-10-27	2016-09-30	0.53	0.53	0.0	0
2016-07-28	2016-06-30	0.56	0.59	0.03	5
2016-04-28	2016-03-31	0.51	0.53	0.02	3
2016-02-18	2015-12-31	0.47	0.47	0.0	0
2015-10-29	2015-09-30	0.43	0.44	0.01	2
2015-07-30	2015-06-30	0.45	0.47	0.02	4
2015-04-30	2015-03-31	0.4	0.45	0.05	12
2015-02-19	2014-12-31	0.46	0.45	-0.01	2
2014-10-30	2014-09-30	0.43	0.44	0.01	2
2014-07-31	2014-06-30	0.47	0.52	0.05	10
2014-05-01	2014-03-31	0.41	0.38	-0.03	7
2014-02-20	2013-12-31	0.38	0.38	0.0	0
2013-10-31	2013-09-30	0.36	0.39	0.03	8
2013-08-01	2013-06-30	0.41	0.43	0.02	4
2013-05-02	2013-03-31	0.43	0.44	0.01	2
2013-02-21	2012-12-31	0.28	0.31	0.03	10
2012-11-01	2012-09-30	0.25	0.26	0.01	4
2012-08-02	2012-06-30	0.34	0.4	0.06	17
2012-04-26	2012-03-31	0.33	0.42	0.09	27
2012-02-16	2011-12-31	0.28	0.3	0.02	7
2011-11-01	2011-09-30	0.26	0.27	0.01	3
2011-07-28	2011-06-30	0.34	0.31	-0.03	8
2011-04-28	2011-03-31	0.31	0.3	-0.01	3
2011-02-17	2010-12-31	0.23	0.21	-0.02	8
2010-11-02	2010-09-30	0.21	0.23	0.02	9
2010-08-03	2010-06-30	0.31	0.32	0.01	3
2010-04-29	2010-03-31	0.26	0.29	0.03	11
2010-02-18	2009-12-31	0.32	0.34	0.02	6
2009-11-03	2009-09-30	0.26	0.23	-0.03	11
2009-08-04	2009-06-30	0.25	0.29	0.04	16
2009-04-30	2009-03-31	0.21	0.21	0.0	0
2009-02-19	2008-12-31	0.26	0.28	0.02	7
2008-11-04	2008-09-30	0.23	0.19	-0.04	17
2008-08-05	2008-06-30	0.33	0.37	0.04	12
2008-05-01	2008-03-31	0.34	0.36	0.02	5
2008-02-21	2007-12-31	0.24	0.26	0.02	8
2007-11-01	2007-09-30	0.21	0.21	0.0	0
2007-08-02	2007-06-30	0.35	0.34	-0.01	2
2007-04-26	2007-03-31	0.33	0.39	0.06	18
2007-02-20	2006-12-31	0.21	0.22	0.01	4
2006-11-02	2006-09-30	0.16	0.19	0.03	18
2006-08-03	2006-06-30	0.3	0.31	0.01	3
2006-04-27	2006-03-31	0.23	0.27	0.04	17
2006-02-21	2005-12-31	0.18	0.2	0.02	11
2005-10-20	2005-09-30	0.16	0.11	-0.05	31
2005-07-21	2005-06-30	0.21	0.2	-0.01	4
2005-04-21	2005-03-31	0.17	0.21	0.04	23
2005-02-22	2004-12-31	0.1	0.12	0.02	20
2004-10-19	2004-09-30	0.1	0.11	0.01	10
2004-07-20	2004-06-30	0.16	0.17	0.01	6
2004-04-20	2004-03-31	0.13	0.15	0.02	15
2004-02-17	2003-12-31	0.1	0.1	0.0	0
2003-10-21	2003-09-30	0.09	0.08	-0.01	11
2003-07-22	2003-06-30	0.13	0.16	0.03	23
2003-04-22	2003-03-31	0.09	0.12	0.03	33
2003-02-20	2002-12-31	0.07	0.07	0.0	0
2002-10-24	2002-09-30	0.05	0.06	0.01	20
2002-07-18	2002-06-30	0.12	0.09	-0.03	25
2002-04-18	2002-03-31	0.11	0.1	-0.01	9
2002-02-14	2001-12-31	0.07	0.1	0.03	42
2001-10-17	2001-09-30	0.07	0.07	0.0	0
2001-07-19	2001-06-30	0.09	0.11	0.02	22
2001-02-27	2000-12-31	0.06	0.04	-0.02	33
2000-10-16	2000-09-30	0.08	0.08	0.0	0
2000-07-20	2000-06-30	0.12	0.09	-0.03	25
2000-04-19	2000-03-31	0.11	0.09	-0.02	18
2000-02-15	1999-12-31	0.15	0.14	-0.01	6
1999-10-20	1999-09-30	0.15	0.13	-0.02	13
1999-07-22	1999-06-30	0.17	0.17	0.0	0
1999-04-21	1999-03-31	0.14	0.16	0.02	14
1997-07-17	1997-06-30	0.16	0.15	-0.01	6
1997-04-17	1997-03-31	0.14	0.13	-0.01	7
1997-02-18	1996-12-31	0.13	0.15	0.02	15
1996-10-16	1996-09-30	0.09	0.1	0.01	11
1996-07-18	1996-06-30	0.12	0.13	0.01	8
1996-04-18	1996-03-31	0.11	0.1	-0.01	9
1996-02-15	1995-12-31	0.12	0.12	0.0	0
1995-10-19	1995-09-30	0.08	0.06	-0.02	25
1995-07-20	1995-06-30	0.13	0.13	0.0	0
1995-04-20	1995-03-31	0.12	0.13	0.01	8
1995-02-16	1994-12-31	0.11	0.11	0.0	0
1994-10-20	1994-09-30	0.09	0.09	0.0	0
1994-04-21	1994-03-31	0.1	0.11	0.01	10
1994-02-17	1993-12-31	0.08	0.09	0.01	12
1993-10-21	1993-09-30	0.07	0.08	0.01	14

About West Pharmaceutical Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of West Pharmaceutical earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current West Pharmaceutical estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as West Pharmaceutical fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	4.1 B	4.3 B
Retained Earnings Total Equity	3.4 B	3.6 B
Earnings Yield	0.03	0.05
Price Earnings Ratio	39.68	23.18
Price Earnings To Growth Ratio	28.43	29.85

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

West Pharmaceutical Earnings Estimate

West Pharmaceutical Earnings Estimation Breakdown

West Pharmaceutical Earnings Projection Consensus

West Pharmaceutical Earnings History

West Pharmaceutical Quarterly Gross Profit

264.7 Million

West Pharmaceutical Earnings per Share Projection vs Actual

West Pharmaceutical Estimated Months Earnings per Share

West Quarterly Analyst Estimates and Surprise Metrics

About West Pharmaceutical Earnings Estimate

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for West Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY